Table 1.
Clinic-pathological characteristic of the patients with esophageal cancer
| Factors | Patients, n (%) | Median of survival (CI 95%) | Pvalue |
|---|---|---|---|
| Gender | 0.480 | ||
| Male | 70(55.1) | 10(7.97-12.03) | |
| Female | 57(44.9) | 12(6.46-17.54) | |
| Age | <0.001 | ||
| 45 > | 11(8.7) | 25(10.94-31.33) | |
| 46-65 | 54(42.5) | 18(10.94-25.06) | |
| 66 < | 42(48.8) | 6(4.6-7.4) | |
| Setting | 0.148 | ||
| City | 82(64.6) | 10(8.05-11.95) | |
| Village | 45(35.4) | 14(10.05-17.95) | |
| Histological type | <0.001 | ||
| AC | 23(18.1) | 7(4.18-9.82) | |
| SCC | 94(74.0) | 13(9.34-16.66) | |
| Indeterminate | 10(7.9) | 10(7.93-12.07) | |
| Location of tumor | 0.014 | ||
| Lower | 44(34.6) | 7(5.40-8.60) | |
| Middle | 28(22.0) | 18(10.94-25.06) | |
| Upper | 48(37.8) | 12(8.60-15.40) | |
| Overlapping lesion | 7(5.5) | 9(3.92-16.68) | |
| Histology grade | 0.008 | ||
| Poorly | 16(12.6) | 7(1.12-12.88) | |
| Moderately | 35(27.6) | 22(6.06-37.94) | |
| Well | 42(48.8) | 9(6.80-11.20) | |
| No Differential | 14(11.0) | 12(7.41-16.59) | |
| Stage | <0.001 | ||
| Localized | 15(11.8) | 25(12.02-35.98) | |
| Regional | 32(25.2) | 24(13.01-34.99) | |
| Distant | 32(25.2) | 10(6.32-13.68) | |
| Unknown | 38(37.08) | 5(3.88-6.12) | |
| Practice treatment | <0.001 | ||
| surgery | 15(11.8) | 12(4.42-19.57) | |
| chemotropic | 30(23.6) | 5(3.92-6.07) | |
| radiotherapy | 7(5.5) | 5(2.91-7.09) |